
Rachel Meislin, MD, explains that anti-inflammatory reliever and maintenance strategies are standard in pulmonology and ob-gyns should recognize rather than disrupt them.

Rachel Meislin, MD, explains that anti-inflammatory reliever and maintenance strategies are standard in pulmonology and ob-gyns should recognize rather than disrupt them.

Bladder symptoms during IVF carry systemic diagnostic cues, and integrating bladder health screening and pelvic floor referrals into routine IVF consultation—before symptoms develop—improves patient outcomes, according to Aleece Fosnight, MSPAS, PA-C.

Rachel Meislin, MD, describes a structured asthma assessment that evaluates comorbidities, triggers, and adherence together.

A 20-year PMSS analysis identifies cardiovascular conditions as the leading cause of pregnancy-related death.

Rachel Meislin, MD, explains that uncontrolled asthma, not its diagnosis or treatment, drives adverse pregnancy outcomes, framing disease control as a fetal-protective strategy.

Livi was cleared by the FDA on March 24, 2026 as a novel device to support vaginal health.

This review examines labial agglutination in prepubescent girls, covering etiology, diagnosis, and conservative, education-focused management strategies.

Liz Miracle, PT, MPT, WCS, discusses clinician-identified advantages of virtual pelvic health care, including access, psychological safety, and in-home assessment.

Over 27% of OUD pregnancies had no HCV testing, and only 9.7% with active infection received postpartum DAAs.

Jeff Andrews, MD, FRCSC, discusses raising awareness of at-home HPV self-collection and identifying appropriate candidates as the option rolls out in the US.

TMP-SMX was linked to higher UTI treatment failure vs. nitrofurantoin and fosfomycin in postmenopausal women.

Post-retrieval urinary symptoms often reflect physiologic changes rather than infection; urinalysis and culture should precede antibiotic prescribing, says Aleece Fosnight, MSPAS, PA-C.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

Mark N. Simon, MD, MMM, discusses the clinical risks tied to maternity care deserts and longer travel times following new March of Dimes data.

“Primary care physicians, who traditionally have referred out for speculum exams, can now offer self-collection during routine appointments or problem visits, preventing missed opportunities for patient preventive care,” said Andrews.

A new cohort study links estrogen-only MHT use to reduced Alzheimer disease pathology.

Liz Miracle, PT, MPT, WCS, argues that ACOG Committee Opinion No. 736, which supports non-office postpartum assessment, applies equally to virtual pelvic floor physical therapy.

Included are statements from SMFM, ACOG, and the AAP.

A new LifeStance survey finds many women are unaware that perimenopause can affect mental health.

One in 3 counties in the United States remain maternity care deserts as 96 L&D closures compound access gaps, per March of Dimes.

Women with type 2 diabetes reported more and worse menopause symptoms, especially in the postmenopause stage.

AbCellera's ABCL635 met primary efficacy endpoints in a Phase 2 trial for moderate-to-severe hot flashes.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

Liz Miracle, PT, MPT, WCS, discusses a retrospective analysis of 4,662 patients finding comparable pelvic health outcomes across virtual, hybrid, and in-person care.

Damian Alagia, III, MD, attributes gaps in prenatal STI detection and treatment to systemic flaws in access rather than individual clinical judgment.

This review aims to go beyond the basics by exploring advanced interpretations for clinical referral to support ob-gyn providers in translating urinalysis findings into practical care decisions.

A University of Michigan pilot study, discussed here by lead researcher Alex F. Peahl, MD, MSc, found patient-operated remote ultrasonography feasible for completing biophysical profiles in high-risk pregnancies.

The FDA has cleared the Revi Extend, furthering the system's lifespan to 15 years to treat UUI.

Michael A. Reed, MD, MSCP, outlines immediate, practical steps physicians can take to address women's sexual health in their current roles.

Jeffrey Jensen, MD, MPH, explains the Gwyn Lo patch's Pearl Index following its recent FDA approval.